Discovery Europe 2024

22 - 23 May 2024 | Basel, Switzerland

Together with Neuroscience Drug Development Europe, attendees especially benefit from a 2-day event addressing emerging strategies for the drug development of neuroscience.

Presentation Speaker
Overview Drug Discovery Summit & Discovery Chemistry Europe Neuroscience Drug Development Europe
+co-located event:
Automate Europe 2024

Explore Discovery Europe 2024: Unlocking Future Insights in Advancing Drug Discovery Pipelines & Research 

Discovery Europe 2024 features the co-location of 22nd Annual Drug Discovery Summit & Discovery Chemistry Europe and the 5th Annual Neuroscience Drug Development Europe Congresses.

Join and network with over 350 industry discovery biology and chemistry leaders at the renowned Drug Discovery Summit in Basel, where they address critical strategies in target identification, validation and HIT optimisation of small and large molecule drugs. The Drug Design & Medicinal Chemistry focused event also offer insightful innovations in Automation And Synthesis In Organic Chemistry as well as Molecular Drug Design.

Together with Neuroscience Drug Development Europe, attendees especially benefit from a 2-day event addressing emerging strategies for the drug development of neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative diseases.

22nd Annual Drug Discovery Summit & Discovery Chemistry Europe Congress

Join and network with over 230 industry leaders at the renowned Drug Discovery Summit in Basel, where we will address the latest advancements in target identification, validation and HIT optimisation. The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics - based discovery, Organ-on-a-chip and 3D modelling. Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.

  • The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
  • Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.
  • Join our 2-day innovation showcase situated alongside the main programme, which aims to inspire growth and create collaboration opportunities for all who attend.

Agenda at a Glance


  • Workshop 1: Organ Modelling
  • Workshop 2: Targeted Protein Degradation
  • Workshop 3: Automation or AI in Medicinal Chemistry and Drug Design

Drug Discovery Summit

  • Day One, Track 1: Identification And Validation Of Novel Targets For Next Generation Therapeutics
  • Day One, Track 2: Animal And Disease Modelling, Organoid And Organ On The Chip Based Discovery
  • Day One, Track 3: Discovery on Target – Screening and Genomic Strategies
  • Day Two, Track 1: Phenotypic & Target Based Discovery Approaches

Drug Design & Medicinal Chemistry Summit

  • Day One, Track 1: Computational Drug Design: AI In Chemical Synthesis, Target ID Capabilities, Lead Identification, Lead Optimisation, Measuring PK/PD & Prediction
  • Day Two, Track 2: Hit Finding Technologies And Advancements
  • Day Two, Track 3, Part 1: Automation And Synthesis In Organic Chemistry
  • Day Two, Track 3, Part 2: Molecular Drug Design And Med Chem: Innovations In Fragment & Structured Based Drug Discovery

5th Annual Neuroscience Drug Development Europe Congress

A thorough, 2-day event addressing emerging strategies for the drug development of neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative diseases.

  • Examine the latest advancements and emerging trends in developing neurological treatments, including targeted approaches and novel strategies.
  • Discuss the pioneering innovations in stem cell technologies, with the latest updates on iPS cells for disease modelling and drug discovery. 
  • Establish in-depth knowledge of cutting-edge recent advances in gene therapy for CNS drug discovery and current opportunities for digital biomarkers in neuroscience.

Agenda at a Glance


Day One, Track 1: Therapeutic Strategies, Enabling Technologies & Biomarker Development

Day Two, Track 1: Drug Discovery For Neurodegenerative Disease

3rd Annual SmartLabs Automation & Robotics Congress

Attendees of Discovery Europe 2024 also have access to Automate Europe 2024

Explore Automate Europe 2024: Unlocking Future Insights in Automation & Robotics Research and Development  

Automate 2024 consists of the 3rd Annual SmartLabs Automation & Robotics Congress, at which visionary leaders will discuss the current state of the industry, market trends and future growth areas pushing the pharma automation industry in the future. Join leaders, experts and researchers and discuss digital QA/QC labs, accelerating digital transformation, lab robotics & tools for drug discovery workflows, robotic process automation and implementing AI/ML in the lab. Automation of pharma manufacturing and the application of mobile robotics in QA/QC labs will also be discussed.

  • The 2-day programme features the innovation and advancement in mobile robot technology and applications, and competitive advantages that can be gained in drug development and pharma manufacturing, automation and logistics.
  • Learn about key focus areas in developments in the automation & digitisation of QA/QC labs, accelerating digital transformation, lab robotics & tools for drug discovery workflows, robotic, process automation and implementing AI/ML in the lab.

Agenda at a Glance


  • Day One, Track 1: Bridging The Gap Between Automation & Digitalisation through FAIR & Digital Transformation 
  • Day One, Track 2: Smart Manufacturing & Digitisation Optimisation
  • Day One, Track 3: Mobile Robotics In R&D Laboratories
  • Day Two, Track 1: Automation with AI/ML & Robotics Tools in Drug Discovery & Development 
  • Day Two, Track 2: Data-Driven Modelling & Data Analytics for Drug Discovery & Development 

What to Expect

350

leading pharma, biotech & academic delegates

35
hours of presentations, discussions & interactive content
9
hours of networking breaks, including speed networking & refreshments
240
pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 100 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Discovery Europe 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Berengere Dumotier
ASSOCIATE DIRECTOR,
NOVARTIS
Davide Gianni
Senior Director,
Astrazeneca
Geoffrey Kerchner
Vice President, Global Head of Early Development - Neuroscience & Rare Diseases,
Hoffmann La Roche Ltd
Giovanna Lalli
Director of Scientific Affairs,
UK Dementia Research Institute
Irene Choi
Director, Drug Discovery,
Verge Genomics
Janet Brownlees
Senior Director,
Merck Sharpe and Dohme
Johan Luthman
Executive Vice President of R&D,
Lundbeck
Sanne Glad
Scientific Director,
Amgen Research Copenhagen

All Speakers

Amelie Joffrin
Investigator, Chemical Biology,
GSK
Andrew Beggs
Professor,
University of Birmingham
Anna Vulpetti
Associate Director,
Novartis
Arianna Sabò
Head of R&D,
QUANTRO Therapeutics GmbH
Borislav Dejanovic
Senior Director,
Vigil Neuroscience
Carl Poelking
Associate Director,
Astex
Daohong Zhou
Professor and Director,
Center for Innovative Drug Discovery, University of Texas Health San Antonio
Dave Bearss
CEO,
Halia
Diana Zindel
Associate Director,
AstraZeneca
Domagoj Vucic
Senior Fellow,
Genentech
Emma Davies
Associate Director - Preclinical,
Healx
Eric R Goedken
Senior Principal Research Scientist, Dermatology, Immunology Discovery,
AbbVie
Filip Roudnicky
Senior Principal Scientist,
F.Hoffmann-La Roche Ltd
Gebhard Thoma
Associate Director,
Novartis
Gergely Toth
CEO,
Cantabio Pharmaceuticals
Giovanni Spagnolli
CTO,
Sibylla Biotech
Graham Dempsey
Chief Scientific Officer,
Quiver Bioscience
Gregori Gerebtzoff
Director,
Novartis
Gregory Hollingworth
Director, Chemistry and TPD/Proximity Initiative co-Lead,
Novartis
Hai Rao
Professor and Chair of Biochemistry,
Southern University of Science and Technology
Jacques Dumas
Chief Scientific Officer,
Arrakis Therapeutics
James Overell
Group Medical Director,
Roche
Jon Lea
Team Leader,
GSK
Jonathan Mason
Senior Research Fellow,
Sosei Heptares
Jose Luis Molinuevo
VP Head of Exp Med,
H. Lundbeck A/S
Julian Röwe
Senior Scientist,
Babraham Institute
Kerstin Hofer
Senior Scientist and Matrix Lead,
Roche
Ludovic Collin
Head of Neuroimmunology,
Roche
Manuel Stritt
Head Scientific Computing Drug Discovery,
Idorsia Pharmaceuticals Ltd
Mark McAlister
Director of Biophysics,
Astrazeneca
Markus Schade
Principal Scientist,
AstraZeneca
Mirko Messa
Associate Director,
AstraZeneca
Mo Lotfollahi
Director of Machine Learning Research,
Relation Therapeutics
Morten Grunnet
Vice President, Head of Neuroscience, Professor,
Lundbeck
Nathalie Cartier-Lacave
Vice President Neurobiology, CNS Sector Lead, Askbio Paris Site Head,
AskBio
Nils Hansen
Chief Executive Officer,
Vipergen
Oliver Hucke
Associate Director,
Boehringer Ingelheim Pharma GmbH & Co KG
Olivier Loiseleur
Senior Team Leader,
Syngenta
Paulina Kolasinska-Zwierz
Principal Scientist,
Alchemab Therapeutics
Peter Brandt
Head of Chemistry,
Beactica Therapeutics
Richard Lewis
Director, Data Science,
Novartis
Robert Fremeau
Founder and CSO,
BrainStorm Therapeutics, Inc.
Roberto Villaseñor
Principal Scientist,
Roche
Robin Löving
CSO,
Salipro Biotech
Simona Cotesta
Director,
Novartis
Slim Chiha
Co-Founder & CEO,
PROSION Therapeutics
Takhar Kasumov
Associate Professor,
Northeastern Ohio University
Tarek Alec Samad
Senior Vice President, Global Head of Research, Corporate Patents & Trademarks,
Lundbeck
Ulrike Künzel
Associate Principal Scientist,
Astrazeneca
Xinxin Gao
Principal Scientific Manager,
Genentech
Zoran Rankovic
Director, CBT Chemistry Centers,
St Jude Children's Research Hospital

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

NeuralPLexer2 - Has AlphaFold2 Met Its Match?

Iambic Therapeutics’ protein structure predictive model, NeuralPLexer2, surpasses AlphaFold2’s abilities.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

AutoPrognosis, An Innovative Tool Used to Predict Lung Cancer Risk

Machine learning model paves the way for predicting lung cancer.

Plan Your Visit

Congress Center Basel
MCH Swiss Exhibition (Basel) Ltd. Messeplatz 21, CH-4058 Basell

By Rail

Basel is an international rail hub with direct ICE, IC and EC connections to Germany, Austria, Italy, France and the Benelux countries. Messe Basel can be reached in five to ten minutes from the three railway stations in Basel: SBB (Switzerland), SNCF (France) (Frankreich) and DB (Badischer Bahnhof, Germany)

By Tram

From the SBB/SNCF railway station, it’s a ten-minute journey on the No. 1 or 2 Tram to the “Messeplatz/Exhibition Square” stop where Messe Basel and the Congress Center are located. From Badischer Bahnhof railway station, “Messeplatz/Exhibition Square” is the second stop on the No. 2 or 6 tram.

By Air

EuroAirport Basel-Mulhouse-Freiburg is 15 minutes by car from Messe Basel. Basel municipal transport’s No. 50 bus additionally provides a straightforward connection from the airport to the SBB/SNCF railway station. From there, tram No. 1 or 2 will take you directly to Messeplatz/Exhibition Square. From Zurich Airport a direct rail connection will bring you to the SBB/SNCF railway station in Basel in less than an hour. For further information including a map and full directions, please visit: https://www.messe-basel.com/en/about-us/getting-to-messe-basel/

By Car

Basel is located at the point where the Swiss, German and French motorway networks all meet. The exhibition and congress site has its own direct link to the A2 motorway. The “Messe” exit will take you straight to the Messe Basel car park with its 1,200 parking spaces.

Oxford Global has secured a number of bedrooms at the Basel Marriott Hotel at a reduced conference rate:

 

Tuesday 21st May 2024 – £230, breakfast included

Wednesday 22nd May 2024 – £230, breakfast included

*Please note: £30 supplement is applicable for double occupancy

 

Should you wish to book a room, please email help@oxfordglobal.com. The final cut-off date to book bedrooms is Friday 3rd May 2024 – any bookings after this date are subject to availability and rates. Please note that any cancellations within 14 days prior to arrival are subject to cancellation charges.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Discovery Europe 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch